Formulation and Evaluation of Fixed-Dose Combination of Bilayer Gastroretentive Matrix Tablet Containing Atorvastatin as Fast-Release and Atenolol as Sustained-Release
Figure 11
Mean plasma concentration versus time (mean ± S.E.) profile of atenolol following oral administration of marketed ATL sustained release formulation (Aten) and bilayer tablets in healthy rabbits ().
